You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
jakemiller
The emergence of antibiotic-resistant pathogens worldwide poses a serious threat to human health care systems. Very limited progress has been made in recent years in the development of new potent antibiotics, so we need new drug development strategies to overcome superbugs. Some promising natural product candidates are antimicrobial peptides (AMPs) from various organisms, which represent some of the possible solutions against superbugs. Learn more:antimicrobial peptide development services
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.